Legal & General Group Plc increased its holdings in Agilent Technologies Inc (NYSE:A) by 7.2% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,488,708 shares of the medical research company’s stock after acquiring an additional 166,390 shares during the quarter. Legal & General Group Plc owned about 0.80% of Agilent Technologies worth $178,399,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds have also made changes to their positions in the stock. Acadian Asset Management LLC lifted its position in Agilent Technologies by 3,222.4% during the fourth quarter. Acadian Asset Management LLC now owns 37,942 shares of the medical research company’s stock valued at $3,236,000 after buying an additional 36,800 shares during the period. Cambridge Investment Research Advisors Inc. lifted its position in Agilent Technologies by 12.9% during the fourth quarter. Cambridge Investment Research Advisors Inc. now owns 14,046 shares of the medical research company’s stock valued at $1,198,000 after buying an additional 1,603 shares during the period. Integrated Advisors Network LLC purchased a new position in Agilent Technologies during the fourth quarter valued at $292,000. Rockefeller Capital Management L.P. lifted its position in Agilent Technologies by 45.2% during the first quarter. Rockefeller Capital Management L.P. now owns 3,825 shares of the medical research company’s stock valued at $274,000 after buying an additional 1,190 shares during the period. Finally, Swiss National Bank lifted its position in Agilent Technologies by 23.1% during the first quarter. Swiss National Bank now owns 1,201,083 shares of the medical research company’s stock valued at $86,022,000 after buying an additional 225,300 shares during the period.
In other Agilent Technologies news, CEO Michael R. Mcmullen sold 18,018 shares of the business’s stock in a transaction dated Friday, May 8th. The stock was sold at an average price of $80.00, for a total transaction of $1,441,440.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, VP Rodney Gonsalves sold 4,566 shares of the business’s stock in a transaction dated Wednesday, May 27th. The shares were sold at an average price of $85.30, for a total value of $389,479.80. Following the sale, the vice president now owns 102,806 shares of the company’s stock, valued at $8,769,351.80. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 64,426 shares of company stock valued at $5,300,943.
NYSE A traded down $3.65 during trading hours on Thursday, hitting $86.16. The company’s stock had a trading volume of 49,548 shares, compared to its average volume of 2,350,978. Agilent Technologies Inc has a 12 month low of $61.13 and a 12 month high of $93.04. The company’s 50 day simple moving average is $82.02 and its two-hundred day simple moving average is $81.01. The company has a market cap of $27.17 billion, a P/E ratio of 40.55, a price-to-earnings-growth ratio of 2.97 and a beta of 1.13. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.63 and a quick ratio of 1.24.
Agilent Technologies (NYSE:A) last released its quarterly earnings results on Thursday, May 21st. The medical research company reported $0.71 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.61 by $0.10. The business had revenue of $1.24 billion during the quarter, compared to the consensus estimate of $1.20 billion. Agilent Technologies had a return on equity of 20.76% and a net margin of 13.04%. The business’s quarterly revenue was up .2% compared to the same quarter last year. During the same period in the previous year, the company posted $0.71 EPS. As a group, research analysts predict that Agilent Technologies Inc will post 3.04 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th will be paid a dividend of $0.18 per share. The ex-dividend date is Monday, June 29th. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.84%. Agilent Technologies’s dividend payout ratio is currently 23.15%.
Several brokerages have commented on A. Bank of America raised their price objective on Agilent Technologies from $74.00 to $88.00 and gave the company a “neutral” rating in a research report on Friday, May 22nd. Stifel Nicolaus lowered their price target on Agilent Technologies from $85.00 to $73.00 and set a “hold” rating for the company in a research report on Thursday, April 2nd. Zacks Investment Research raised Agilent Technologies from a “sell” rating to a “hold” rating and set a $89.00 price target for the company in a research report on Friday, February 21st. Citigroup lowered their price target on Agilent Technologies from $85.00 to $75.00 and set a “neutral” rating for the company in a research report on Friday, March 20th. Finally, Needham & Company LLC lowered Agilent Technologies from a “buy” rating to a “hold” rating and set a $85.00 price target for the company. in a research report on Monday, February 24th. Eleven investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $85.75.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.
Featured Story: Hang Seng Index (HSI)
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.